112 related articles for article (PubMed ID: 30628471)
1. Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy.
Zou M; Samiullah M; Xu P; Wang S; He J; Wu T; Luo F; Yan J
J Drug Target; 2019 Sep; 27(8):885-895. PubMed ID: 30628471
[TBL] [Abstract][Full Text] [Related]
2. Virus-Inspired Gold Nanorod-Mesoporous Silica Core-Shell Nanoparticles Integrated with tTF-EG3287 for Synergetic Tumor Photothermal Therapy and Selective Therapy for Vascular Thrombosis.
Luo X; Xie J; Zhou Z; Ma S; Wang L; Li M; Liu J; Wang P; Li Y; Luo F; Yan J
ACS Appl Mater Interfaces; 2021 Sep; 13(37):44013-44027. PubMed ID: 34494427
[TBL] [Abstract][Full Text] [Related]
3. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
[TBL] [Abstract][Full Text] [Related]
4. Design and construction of a magnetic targeting pro-coagulant protein for embolic therapy of solid tumors.
Zou M; Xu P; Wang L; Wang L; Li T; Liu C; Shi L; Xie J; Li W; Wang S; Wu G; Luo F; Wu T; Yan J
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):116-128. PubMed ID: 31852257
[TBL] [Abstract][Full Text] [Related]
5. Construction and characterization of a truncated tissue factor‑coagulation‑based composite system for selective thrombosis in tumor blood vessels.
Xu P; Zou M; Wang S; Li T; Liu C; Wang L; Wang L; Luo F; Wu T; Yan J
Int J Oncol; 2019 Oct; 55(4):823-832. PubMed ID: 31432158
[TBL] [Abstract][Full Text] [Related]
6. pH-Responsive Liposomes Loaded with Targeting Procoagulant Proteins as Potential Embolic Agents for Solid Tumor-Targeted Therapy.
Wang L; Wang L; Xu P; Liu C; Wang S; Luo X; Li M; Liu J; Zhao Z; Lai W; Luo F; Yan J
Mol Pharm; 2022 May; 19(5):1356-1367. PubMed ID: 35420039
[TBL] [Abstract][Full Text] [Related]
7. pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth.
Li S; Tian Y; Zhao Y; Zhang Y; Su S; Wang J; Wu M; Shi Q; Anderson GJ; Thomsen J; Zhao R; Ji T; Wang J; Nie G
Oncotarget; 2015 Sep; 6(27):23523-32. PubMed ID: 26143637
[TBL] [Abstract][Full Text] [Related]
8. Fusion protein tTF-EG3287 induces occlusion of tumor vessels and impairs tumor growth in human colon caner.
Qiu GQ; Xie X; Zhao B; Xu LZ; Chen YQ
Neoplasma; 2019 Mar; 66(2):252-260. PubMed ID: 30569722
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
10. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
[TBL] [Abstract][Full Text] [Related]
12. A peptide competing with VEGF165 binding on neuropilin-1 mediates targeting of a chlorin-type photosensitizer and potentiates its photodynamic activity in human endothelial cells.
Tirand L; Frochot C; Vanderesse R; Thomas N; Trinquet E; Pinel S; Viriot ML; Guillemin F; Barberi-Heyob M
J Control Release; 2006 Mar; 111(1-2):153-64. PubMed ID: 16423422
[TBL] [Abstract][Full Text] [Related]
13. Design and screening of a novel neuropilin-1 targeted penetrating peptide for anti-angiogenic therapy in glioma.
Zhao L; Chen H; Lu L; Zhao C; Malichewe CV; Wang L; Guo X; Zhang X
Life Sci; 2021 Apr; 270():119113. PubMed ID: 33508290
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a bicyclic peptide neuropilin-1 (NP-1) antagonist (EG3287) reveals importance of vascular endothelial growth factor exon 8 for NP-1 binding and role of NP-1 in KDR signaling.
Jia H; Bagherzadeh A; Hartzoulakis B; Jarvis A; Löhr M; Shaikh S; Aqil R; Cheng L; Tickner M; Esposito D; Harris R; Driscoll PC; Selwood DL; Zachary IC
J Biol Chem; 2006 May; 281(19):13493-13502. PubMed ID: 16513643
[TBL] [Abstract][Full Text] [Related]
15. Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
Chen X; Lv H; Ye M; Wang S; Ni E; Zeng F; Cao C; Luo F; Yan J
Int J Pharm; 2012 Apr; 426(1-2):248-255. PubMed ID: 22310463
[TBL] [Abstract][Full Text] [Related]
16. Specific tissue factor delivery using a tumor-homing peptide for inducing tumor infarction.
Shi Q; Zhang Y; Liu S; Liu G; Xu J; Zhao X; Anderson GJ; Nie G; Li S
Biochem Pharmacol; 2018 Oct; 156():501-510. PubMed ID: 30222966
[TBL] [Abstract][Full Text] [Related]
17. Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.
Kim JY; Han JH; Park G; Seo YW; Yun CW; Lee BC; Bae J; Moon AR; Kim TH
Oncotarget; 2016 May; 7(22):32449-61. PubMed ID: 27083053
[TBL] [Abstract][Full Text] [Related]
18. Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience.
Bieker R; Kessler T; Schwöppe C; Padró T; Persigehl T; Bremer C; Dreischalück J; Kolkmeyer A; Heindel W; Mesters RM; Berdel WE
Blood; 2009 May; 113(20):5019-27. PubMed ID: 19179306
[TBL] [Abstract][Full Text] [Related]
19. Neuropilin-1-Targeted Nanomedicine for Spatiotemporal Tumor Suppression through Photodynamic Vascular Damage and Antiangiogenesis.
Li XY; Yan N; Wu YY; Kong RJ; Qiu ZW; Liu SP; Wu DH; Cheng H
ACS Appl Mater Interfaces; 2024 May; 16(17):21709-21721. PubMed ID: 38651381
[TBL] [Abstract][Full Text] [Related]
20. A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1-expressing breast tumour cells.
Barr MP; Byrne AM; Duffy AM; Condron CM; Devocelle M; Harriott P; Bouchier-Hayes DJ; Harmey JH
Br J Cancer; 2005 Jan; 92(2):328-33. PubMed ID: 15655556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
